You just read:

Relmada Therapeutics Announces Issuance of Key U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression and Other Psychiatric Symptoms

News provided by

Relmada Therapeutics, Inc.

Oct 19, 2016, 08:30 ET